Mucormycosis Clinical Trial
Official title:
COVID-19 Associated Mucormycosis: A Multidisciplinary Dilemma in Assiut University Hospital
We aimed to describe the frequency; presentations, predictors, in-hospital outcome of mucormycosis patients in the scope of COVID-19. All patients with COVID-19 associated Mucormycosis (CAM) admitted to Assuit University Hospital between March 1, 2021, and July 30, 2021, were included in this study. The patient characteristics, the site of mucormycosis, the comorbidities, the steroids usage, and the outcome were analyzed in people with COVID-19.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03387696 -
Mucormycosis in ICU
|
||
| Recruiting |
NCT04744454 -
Post Marketing Surveillance (PMS) Study of Cresemba in Korea.
|
||
| Completed |
NCT00419770 -
The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study
|
Phase 2 | |
| Recruiting |
NCT05925660 -
Mucorales PCR Screening in At-risk Hematology Patients
|
N/A | |
| Completed |
NCT04935463 -
Mucormycosis in COVID-19
|
||
| Completed |
NCT04550936 -
Patterns of Real-World Isavuconazole Use - a Study of Patients With Mucormycosis or Invasive Aspergillosis
|
||
| Not yet recruiting |
NCT05406037 -
Biomarkers for Invasive Mucormycosis
|
||
| Not yet recruiting |
NCT06440915 -
Study on Theraputic Drug Monitoring and Phamacokinetics of Isavuconazole in Children
|
N/A | |
| Completed |
NCT02845934 -
Prospective Evaluation of a New Molecular Tool for Early Diagnosis of Mucormycosis
|
N/A | |
| Completed |
NCT05348434 -
Evaluation of Using 3D Printed PEEK Facial Implants in Repairing Maxillofacial Deformities
|
||
| Completed |
NCT05212961 -
COVID-19 and Rhino-orbital Mucormycosis
|
||
| Recruiting |
NCT05097664 -
Ocular Manifestation and Related Risk Factors of Covid-19 Associated Mucormycosis: a Multicenter Study in Iran
|